{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:07:11Z","timestamp":1778760431749,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07017-w","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:25:22Z","timestamp":1777083922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal complications in pediatric sickle cell disease: results from a single-center study"],"prefix":"10.1007","volume":"105","author":[{"given":"Silvio","family":"Marchesani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Scaramuzzino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Schettini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Fini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Ceglie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"7017_CR1","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP (2018) Sickle cell disease. Nat Rev Dis Primers 4:18010","journal-title":"Nat Rev Dis Primers"},{"key":"7017_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1056\/NEJM199709113371107","volume":"337","author":"HF Bunn","year":"1997","unstructured":"Bunn HF (1997) Pathogenesis and treatment of sickle cell disease. N Engl J Med 337:762\u2013769","journal-title":"N Engl J Med"},{"key":"7017_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"14","author":"P Sundd","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM (2019) Pathophysiology of Sickle Cell Disease. Annu Rev Pathol 14:263\u2013292","journal-title":"Annu Rev Pathol"},{"key":"7017_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3324\/haematol.10937","volume":"92","author":"P Telfer","year":"2007","unstructured":"Telfer P, Coen P, Chakravorty S, Wilkey O, Evans J, Newell H, Smalling B, Amos R, Stephens A, Rogers D, Kirkham F (2007) Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica 92:905\u2013912","journal-title":"Haematologica"},{"key":"7017_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000494581","volume":"47","author":"KO Olaniran","year":"2019","unstructured":"Olaniran KO, Eneanya ND, Nigwekar SU, Vela-Parada XF, Achebe MM, Sharma A, Thadhani RI (2019) Sickle Cell Nephropathy in the Pediatric Population. Blood Purif 47:205\u2013213","journal-title":"Blood Purif"},{"key":"7017_CR6","doi-asserted-by":"crossref","unstructured":"Um N, Cc O, Hu O, Ki A (2020) Sickle cell nephropathy and associated factors among asymptomatic children with sickle cell anaemia [Internet]. International Journal of Pediatrics. [cited 2024 Jul 19] Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.opbg.idm.oclc.org\/32908550\/","DOI":"10.1155\/2020\/1286432"},{"key":"7017_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2217\/bmm-2019-0105","volume":"13","author":"AR Belis\u00e1rio","year":"2019","unstructured":"Belis\u00e1rio AR, da Silva AA, Silva CV, de Souza LM, Wakabayashi EA, Ara\u00fajo S, de Simoes-E-Silva A (2019) Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients. Biomark Med 13:967\u2013987","journal-title":"Biomark Med"},{"key":"7017_CR8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s11739-019-02160-x","volume":"14","author":"VM Pinto","year":"2019","unstructured":"Pinto VM, Balocco M, Quintino S, Forni GL (2019) Sickle cell disease: a review for the internist. Intern Emerg Med 14:1051\u20131064","journal-title":"Intern Emerg Med"},{"key":"7017_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00467-021-05126-4","volume":"37","author":"OC Adebayo","year":"2022","unstructured":"Adebayo OC, Van den Heuvel LP, Olowu WA, Levtchenko EN, Labarque V (2022) Sickle cell nephropathy: insights into the pediatric population. Pediatr Nephrol 37:1231\u20131243","journal-title":"Pediatr Nephrol"},{"key":"7017_CR10","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1046\/j.1523-1755.2002.00363.x","volume":"61","author":"DE Wesson","year":"2002","unstructured":"Wesson DE (2002) The initiation and progression of sickle cell nephropathy. Kidney Int 61:2277\u20132286","journal-title":"Kidney Int"},{"key":"7017_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrneph.2015.8","volume":"11","author":"KA Nath","year":"2015","unstructured":"Nath KA, Hebbel RP (2015) Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol 11:161\u2013171","journal-title":"Nat Rev Nephrol"},{"key":"7017_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41581-019-0181-0","volume":"15","author":"K Van Avondt","year":"2019","unstructured":"Van Avondt K, Nur E, Zeerleder S (2019) Mechanisms of haemolysis-induced kidney injury. Nat Rev Nephrol 15:671\u2013692","journal-title":"Nat Rev Nephrol"},{"key":"7017_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11906-010-0133-3","volume":"12","author":"RJ Glassock","year":"2010","unstructured":"Glassock RJ (2010) Is the presence of microalbuminuria a relevant marker of kidney disease? Curr Hypertens Rep 12:364\u2013368","journal-title":"Curr Hypertens Rep"},{"key":"7017_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-022-00540-9","volume":"18","author":"KI Ataga","year":"2022","unstructured":"Ataga KI, Saraf SL, Derebail VK (2022) The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol 18:361\u2013377","journal-title":"Nat Rev Nephrol"},{"key":"7017_CR15","first-page":"185","volume":"83","author":"JN Etteldorf","year":"1952","unstructured":"Etteldorf JN, Tuttle AW, Clayton GW (1952) Renal function studies in pediatrics. 1. Renal hemodynamics in children with sickle cell anemia. AMA Am J Dis Child 83:185\u2013191","journal-title":"AMA Am J Dis Child"},{"key":"7017_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jpeds.2009.06.060","volume":"156","author":"RE Ware","year":"2010","unstructured":"Ware RE, Rees RC, Sarnaik SA, Iyer RV, Alvarez OA, Casella JF, Shulkin BL, Shalaby-Rana E, Strife CF, Miller JH, Lane PA, Wang WC, Miller ST (2010) BABY HUG Investigators. Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial. J Pediatr 156:66\u201370e1","journal-title":"J Pediatr"},{"key":"7017_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1053\/j.ackd.2022.03.004","volume":"29","author":"P Amarapurkar","year":"2022","unstructured":"Amarapurkar P, Roberts L, Navarrete J, El Rassi F (2022) Sickle Cell Disease and Kidney. Adv Chronic Kidney Dis 29:141\u2013148e1","journal-title":"Adv Chronic Kidney Dis"},{"key":"7017_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"7017_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"7017_CR20","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease","year":"2024","unstructured":"Kidney Disease (2024) Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 105:S117\u2013S314","journal-title":"Kidney Int"},{"key":"7017_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/j.ajkd.2022.02.022","volume":"80","author":"MK Saha","year":"2022","unstructured":"Saha MK, Massicotte-Azarniouch D, Reynolds ML, Mottl AK, Falk RJ, Jennette JC, Derebail VK (2022) Glomerular Hematuria and the Utility of Urine Microscopy: A Review. Am J Kidney Dis 80:383\u2013392","journal-title":"Am J Kidney Dis"},{"key":"7017_CR22","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s00467-022-05827-4","volume":"38","author":"H Pottel","year":"2023","unstructured":"Pottel H, Adebayo OC, Nkoy AB, Delanaye P (2023) Glomerular hyperfiltration: part 1 - defining the threshold - is the sky the limit? Pediatr Nephrol 38:2523\u20132527","journal-title":"Pediatr Nephrol"},{"key":"7017_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jcmg.2015.05.013","volume":"9","author":"O Niss","year":"2016","unstructured":"Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, Kimball TR, Towbin JA, Malik P, Taylor MD (2016) Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease. JACC Cardiovasc Imaging 9:243\u2013252","journal-title":"JACC Cardiovasc Imaging"},{"key":"7017_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/jcm12010007","volume":"12","author":"L Sabatini","year":"2022","unstructured":"Sabatini L, Chinali M, Franceschini A, Di Mauro M, Marchesani S, Fini F, Arcuri G, Lodi M, Palumbo G, Ceglie G (2022) Echocardiographic Evaluation in Paediatric Sickle Cell Disease Patients: A Pilot Study. J Clin Med 12:7","journal-title":"J Clin Med"},{"key":"7017_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jpeds.2015.10.085","volume":"170","author":"M Chinali","year":"2016","unstructured":"Chinali M, Emma F, Esposito C, Rinelli G, Franceschini A, Doyon A, Raimondi F, Pongiglione G, Schaefer F, Matteucci MC (2016) Left Ventricular Mass Indexing in Infants, Children, and Adolescents: A Simplified Approach for the Identification of Left Ventricular Hypertrophy in Clinical Practice. J Pediatr 170:193\u2013198","journal-title":"J Pediatr"},{"key":"7017_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1161\/CIRCIMAGING.112.974428","volume":"5","author":"P Bhatla","year":"2012","unstructured":"Bhatla P, Nielsen JC, Ko HH, Doucette J, Lytrivi ID, Srivastava S (2012) Normal values of left atrial volume in pediatric age group using a validated allometric model. Circ Cardiovasc Imaging 5:791\u2013796","journal-title":"Circ Cardiovasc Imaging"},{"key":"7017_CR27","first-page":"632","volume":"76","author":"FE Hatch","year":"1970","unstructured":"Hatch FE, Azar SH, Ainsworth TE, Nardo JM, Culbertson JW (1970) Renal circulatory studies in young adults with sickle cell anemia. J Lab Clin Med 76:632\u2013640","journal-title":"J Lab Clin Med"},{"key":"7017_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/0895-4356(92)90073-V","volume":"45","author":"MS West","year":"1992","unstructured":"West MS, Wethers D, Smith J, Steinberg M (1992) Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. J Clin Epidemiol 45:893\u2013909","journal-title":"J Clin Epidemiol"},{"key":"7017_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1080\/08880018.2021.1894280","volume":"38","author":"D Hanna","year":"2021","unstructured":"Hanna D, Beshir M, Khalifa N, Baz E, Elhewala A (2021) Assessment of cystatin C in pediatric sickle cell disease and \u03b2-thalassemia as a marker of subclinical cardiovascular dysfunction: a case-control study. Pediatr Hematol Oncol 38:620\u2013632","journal-title":"Pediatr Hematol Oncol"},{"key":"7017_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bcmd.2014.07.018","volume":"54","author":"M Asnani","year":"2015","unstructured":"Asnani M, Reid M, Cystatin C (2015) a useful marker of glomerulopathy in sickle cell disease? Blood Cells Mol Dis 54:65\u201370","journal-title":"Blood Cells Mol Dis"},{"key":"7017_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/ajh.25390","volume":"94","author":"JD Lebensburger","year":"2019","unstructured":"Lebensburger JD, Aban I, Pernell B, Kasztan M, Feig DI, Hilliard LM, Askenazi DJ (2019) Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy. Am J Hematol 94:417\u2013423","journal-title":"Am J Hematol"},{"key":"7017_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/bjh.17832","volume":"196","author":"OC Adebayo","year":"2022","unstructured":"Adebayo OC, Betukumesu DK, Nkoy AB, Adesoji OM, Ekulu PM, Van den Heuvel LP, Levtchenko EN, Labarque V (2022) Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia. Br J Haematol 196:204\u2013214","journal-title":"Br J Haematol"},{"key":"7017_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa2203769","volume":"388","author":"H Pottel","year":"2023","unstructured":"Pottel H, Bj\u00f6rk J, Rule AD, Ebert N, Eriksen BO, Dubourg L, Vidal-Petiot E, Grubb A, Hansson M, Lamb EJ, Littmann K, Mariat C, Melsom T, Schaeffner E, Sundin P-O, \u00c5kesson A, Larsson A, Cavalier E, Bukabau JB, Sumaili EK, Yayo E, Monnet D, Flamant M, Nyman U, Delanaye P (2023) Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex. N Engl J Med 388:333\u2013343","journal-title":"N Engl J Med"},{"key":"7017_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fped.2016.00106","volume":"4","author":"IF Shatat","year":"2016","unstructured":"Shatat IF, Qanungo S, Hudson S, Laken MA, Hailpern SM (2016) Changes in Urine Microalbumin-to-Creatinine Ratio in Children with Sickle Cell Disease over Time. Front Pediatr 4:106","journal-title":"Front Pediatr"},{"key":"7017_CR35","doi-asserted-by":"publisher","first-page":"e237545","DOI":"10.1136\/bcr-2020-237545","volume":"14","author":"M Cunha","year":"2021","unstructured":"Cunha M, Sim\u00e3o C, Ferr\u00e3o A, Palar\u00e9 MJ (2021) Nephrotic syndrome on sickle cell disease: the impact of Hydroxyurea. BMJ Case Rep 14:e237545","journal-title":"BMJ Case Rep"},{"key":"7017_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J (2014) Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 312:1033\u20131048","journal-title":"JAMA"},{"key":"7017_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/ajh.23762","volume":"89","author":"KI Ataga","year":"2014","unstructured":"Ataga KI, Derebail VK, Archer DR (2014) The glomerulopathy of sickle cell disease. Am J Hematol 89:907\u2013914","journal-title":"Am J Hematol"},{"key":"7017_CR38","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.34067\/KID.0003222020","volume":"1","author":"M Kallash","year":"2020","unstructured":"Kallash M, Rheault MN (2020) Approach to persistent microscopic hematuria in children. Kidney360 1:1014\u20131020","journal-title":"Kidney360"},{"key":"7017_CR39","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s00467-010-1560-8","volume":"25","author":"S Gurkan","year":"2010","unstructured":"Gurkan S, Scarponi KJ, Hotchkiss H, Savage B, Drachtman R (2010) Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol 25:2123\u20132127","journal-title":"Pediatr Nephrol"},{"key":"7017_CR40","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00467-010-1536-8","volume":"25","author":"LJ Becton","year":"2010","unstructured":"Becton LJ, Kalpatthi RV, Rackoff E, Disco D, Orak JK, Jackson SM, Shatat IF (2010) Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 25:1505\u20131511","journal-title":"Pediatr Nephrol"},{"key":"7017_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00246-006-1390-4","volume":"28","author":"F Assadi","year":"2007","unstructured":"Assadi F (2007) Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol 28:27\u201333","journal-title":"Pediatr Cardiol"},{"key":"7017_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fmed.2018.00323","volume":"5","author":"A Menet","year":"2018","unstructured":"Menet A, Ranque B, Diop IB, Kingue S, N\u2019guetta R, Diarra M, Diallo D, Diop S, Diagne I, Sanogo I, Chelo D, Wamba G, Deme-Ly I, Faye BF, Seck M, Tolo A, Boidy K, Koffi G, Abough EC, Diakite CO, Traore Y, Legueun G, Kamara I, Offredo L, Marechaux S, Mirabel M, Jouven X (2018) Subclinical Cardiac Dysfunction Is Associated With Extracardiac Organ Damages. Front Med (Lausanne) 5:323","journal-title":"Front Med (Lausanne)"},{"key":"7017_CR43","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/echo.14028","volume":"35","author":"S Chiadika","year":"2018","unstructured":"Chiadika S, Lim-Fung M, Llanos-Chea F, Serauto Canache A, Yang W, Paruthi C, Zhang X, McPherson DD, Idowu M (2018) Echocardiographic parameters to identify sickle cell patients with cardio-pathology. Echocardiography 35:1271\u20131276","journal-title":"Echocardiography"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07017-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:07:21Z","timestamp":1778756841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07017-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["7017"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07017-w","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}